News | Neuro Imaging | June 08, 2016

Brain MRI Scans May Predict Behavior

NIH project data suggest individual differences in brain connectivity can reliably predict behavior

NIH, Human Connectome Project, HCP, brain MRI, predict behavior

This High Angular Resolution Diffusion Image (HARDI) of the human brain shows long distance connections, or tracts, grouped on the basis of their anatomical neighborhood. Wiring associated with particular brain structures share the same color. In diffusion imaging, the scanner detects movement of water inside neural fibers to reveal their locations.Anastasia Yendiki, Ph.D., Viviana Siless, Ph.D., MGH/Harvard, Boston Adolescent Neuroimaging of Depression and Anxiety (BANDA)

June 8, 2016 — Scans of an individual’s brain activity are emerging as powerful predictive tools, thanks to the Human Connectome Project (HCP), an initiative of the National Institutes of Health. Recently reported studies based on HCP neuroimaging and psychological data show that individual differences in brain connectivity can reliably predict a person’s behavior.

Such individual differences were often discarded as “noise” – uninterpretable apart from group data. These scans might someday help clinicians personalize diagnosis and treatment of mental disorders, said researchers.

One study found that an individual’s unique resting state connectivity “fingerprint” can accurately predict fluid intelligence. Another developed a model that similarly predicted individuals’ performance on a variety of tasks, including reading and decision-making. Notably, no brain scans or psychological tests were required specifically for these studies; instead, the researchers drew upon a trove of shared data from more than 1,000 subjects made available by the HCP.

This database is one of the achievements being showcased this month, as the NIH celebrates completion of the HCP’s first phase. A symposium, open to the public, spotlighting HCP’s successes to date, will be held on the NIH campus in Bethesda, Md., on June 20, and will also be videocast worldwide.

In 2010, NIH awarded two HCP grants to map the human brain’s connections in high resolution. The aim was to understand the connections of the healthy human brain to establish a baseline that would help identify connectivity abnormalities in brain disorders. The grants supported two research consortia, one led by researchers at Washington University in St. Louis and the University of Minnesota; the other led by investigators at Massachusetts General Hospital (MGH)/Harvard University, Boston, and the University of California Los Angeles (UCLA).

The MGH/UCLA consortium built a custom “Connectom” scanner with advanced diffusion magnetic resonance imaging (MRI) technology that can visualize the brain’s networks in 10-fold higher detail than conventional scanners. At least two other leading research centers have recently adopted the HCP-designed high-powered diffusion imaging scanners — which boost resolving power via magnetically stronger copper coils, called gradients.

In parallel, researchers at Washington University and the University of Minnesota led a multi-institution consortium that comprehensively mapped long-distance brain connections and their variability in 1,200 healthy adults (twins and their non-twin siblings), using both MRI and magnetoencephalography. By pairing studies of structural and functional brain connectivity with extensive behavioral and heritability measures, the project has provided data about brain connectivity, its relationship to behavior, and contributions of environmental and genetic factors to individual differences in brain circuitry.

Technical advances achieved during the project have transformed the field – for example, enabling much more efficient data collection by dramatically shortening the duration of scans while maintaining high-resolution images. The wealth of data gathered has been shared with the wider neuroimaging community via a data archive supported by NIH. These user-friendly tools for data mining, analysis and visualization are enabling discoveries such as those on the predictive power of individual scan data.

The June 20 symposium will also feature reports on the second phase of the HCP, which will collect data from healthy subjects across the human lifespan and from individuals with specific clinical diagnoses.

The HCP is a project of the NIH Blueprint for Neuroscience Research. This collaborative framework includes the NIH Office of the Director and 15 NIH institutes and centers that support research on the nervous system. By pooling resources and expertise, Blueprint identifies cross-cutting areas of research, and confronts challenges too large for any single institute or center.

For more information: www.nih.gov

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Machine Learning IDs Markers to Help Predict Alzheimer's

Neurologists use structural and diffusion magnetic resonance imaging (MRI) to identify changes in brain tissue (both gray and white matter) that are characteristic of Alzheimer's disease and other forms of dementia. The MRI images are analyzed using morphometry and tractography techniques, which detect changes in the shape and dimensions of the brain and in the tissue microstructure, respectively. In this example, the images show the normal brain of an elderly patient. Image courtesy of Jiook Cha.

News | Neuro Imaging | September 20, 2018
New research has shown a combination of two different modes of magnetic resonance imaging (MRI), computer-based...
Ingenia Ambition X 1.5T MR. This innovation is the latest advance in the Ingenia MRI portfolio, which comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that empower a faster, smarter, and simpler path to enabling a confident diagnosis
News | Magnetic Resonance Imaging (MRI) | September 14, 2018
Philips, a global leader in health technology, launched the Ingenia Ambition X 1.5T MR.
Veye Chest version 2
News | Lung Cancer | September 11, 2018
Aidence, an Amsterdam-based medical AI company, announced that Veye Chest version 2, a class IIa medical device, has
Sponsored Content | Case Study | Magnetic Resonance Imaging (MRI) | September 07, 2018 | By Sabine Sartoretti, M.D.
As soon as the Compressed SENSE technology became available to the MRI team at Kantonsspital Winterthur (Switzerland),...

Image courtesy of Philips Healthcare

Feature | Magnetic Resonance Imaging (MRI) | September 06, 2018 | By Melinda Taschetta-Millane
According to the Prescient & Strategic Intelligence report, “Global Magnetic Resonance Imaging (MRI) Market Size,...
PET Imaging Agent Predicts Brain Tau Pathology, Alzheimer's Diagnosis
News | PET Imaging | September 05, 2018
Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced a Phase 3 study of positron emission tomography (PET)...
Check-Cap Announces Interim Results of European Study of C-Scan System Version 3
News | Colonoscopy Systems | September 04, 2018
Check-Cap Ltd. announced the interim results for its post-CE approval study of the C-Scan system Version 3, an...
Brain Iron Levels May Predict Multiple Sclerosis Disabilities
News | Neuro Imaging | August 31, 2018
A new, highly accurate magnetic resonance imaging (MRI) technique can monitor iron levels in the brains of multiple...
Study Finds Multiple Sclerosis Drug Slows Brain Shrinkage

An NIH-funded clinical trial suggested that the anti-inflammatory drug ibudilast may slow brain shrinkage caused by progressive MS. Image courtesy of Robert J. Fox, M.D., Cleveland Clinic.

News | Neuro Imaging | August 30, 2018
August 30, 2018 — Results from a clinical...